...
首页> 外文期刊>Pharmaceutical research >'Click' conjugation of peptide on the surface of polymeric nanoparticles for targeting tumor angiogenesis.
【24h】

'Click' conjugation of peptide on the surface of polymeric nanoparticles for targeting tumor angiogenesis.

机译:多肽在聚合物纳米颗粒表面的“点击”偶联,用于靶向肿瘤血管生成。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Angiogenesis plays a critical role in tumor growth. This phenomena is regulated by numerous mediators such as vascular endothelial growth factor (VEGF). CBO-P11, a cyclo-peptide, has proven to specifically bind to receptors of VEGF and may be used as targeting ligand for tumor angiogenesis. We herein report the design of novel nanoparticles conjugated to CBO-P11 in order to specifically target tumor site. METHODS: The conjugation of CBO-P11 on the surface of poly(vinylidene fluoride) (PVDF) nanoparticles was investigated using the copper(I)-catalyzed Huisgen 1,3-dipolar cycloaddition known as "click" reaction. CBO-P11 was modified with a near-infrared cyanine dye bearing an alkyne function, allowing both "click" coupling on azido-modified nanoparticles and fluorescence labelling. Each step of this nanodevice construction was judiciously performed in aqueous solution and successfully characterized. The cytotoxicity of nanoparticles was evaluated in human brain endothelial cell line and their affinity for VEGF receptors was determined via fluorescence-based uptake assays on porcine aortic endothelial cell line. RESULTS: Nanoparticles were found to be spherical, dense, monodisperse and stable. No cytotoxicity was observed after four days of incubation demonstrating the biocompatibility of nanoparticles. Fluorescence highlighted the specific interaction of these functionalized nanoparticles for VEGF receptors, suggesting that the targeting peptide bioactivity was retained. CONCLUSIONS: These results demonstrate the potential of these functionalized nanoparticles for targeting tumor angiogenesis and their possible use as multifunctional platform for cancer treatment if coupled with therapeutic agents.
机译:目的:血管生成在肿瘤生长中起关键作用。这种现象由多种介体调节,例如血管内皮生长因子(VEGF)。 CBO-P11是一种环肽,已被证明与VEGF受体特异性结合,可以用作肿瘤血管生成的靶向配体。我们在此报告了偶联至CBO-P11的新型纳米颗粒的设计,以便特异性靶向肿瘤部位。方法:使用被称为“点击”反应的铜(I)催化的惠斯根1,3-偶极环加成研究了聚偏二氟乙烯(PVDF)纳米粒子表面上CBO-P11的结合。用带有炔烃功能的近红外花青染料对CBO-P11进行了修饰,从而可以在叠氮基修饰的纳米颗粒上实现“咔嗒”耦合和荧光标记。明智地在水溶液中进行该纳米器件构造的每个步骤,并成功进行了表征。在人脑内皮细胞系中评估了纳米颗粒的细胞毒性,并通过在猪主动脉内皮细胞系上基于荧光的吸收测定法确定了它们对VEGF受体的亲和力。结果:发现纳米颗粒为球形,致密,单分散和稳定。孵育四天后未观察到细胞毒性,表明纳米颗粒具有生物相容性。荧光突出显示了这些功能化的纳米颗粒对VEGF受体的特异性相互作用,表明保留了靶向肽的生物活性。结论:这些结果证明了这些功能化的纳米颗粒具有靶向肿瘤血管生成的潜力,并且如果与治疗剂结合,它们有可能用作癌症治疗的多功能平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号